These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37273749)

  • 21. Perceived Causes of Personal versus Witnessed Overdoses among People who Inject Opioids.
    Behar E; Chang JS; Countess K; Matheson T; Santos GM; Coffin P
    Subst Use Misuse; 2019; 54(12):1929-1937. PubMed ID: 31070106
    [No Abstract]   [Full Text] [Related]  

  • 22. Exploring Canadian perceptions and experiences of stigma during the COVID-19 pandemic.
    Fahim C; Cooper J; Theivendrampillai S; Pham B; Straus SE
    Front Public Health; 2023; 11():1068268. PubMed ID: 36960376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of COVID-19 Among People Who Use Drugs: A Qualitative Study With Harm Reduction Workers and People Who Use Drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Res Sq; 2022 Feb; ():. PubMed ID: 35132406
    [No Abstract]   [Full Text] [Related]  

  • 24. "Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
    Mburu G; Ayon S; Tsai AC; Ndimbii J; Wang B; Strathdee S; Seeley J
    Harm Reduct J; 2018 May; 15(1):29. PubMed ID: 29801494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.
    Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
    Int J Drug Policy; 2021 Oct; 96():103238. PubMed ID: 33902968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers.
    Broady TR; Brener L; Horwitz R; Cama E; Treloar C
    Drug Alcohol Depend; 2023 Aug; 249():109953. PubMed ID: 37302358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions of stigma among people with lived experience of methamphetamine use within the hospital setting: qualitative point-in-time interviews and thematic analyses of experiences.
    Forchuk C; Serrato J; Scott L
    Front Public Health; 2024; 12():1279477. PubMed ID: 38414902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Vaccine Ambivalence Can Lead People Who Inject Drugs to Decline COVID-19 Vaccination and Ways This Can Be Addressed: Qualitative Study.
    Aronson ID; Bennett AS; Ardouin-Guerrier MA; Rivera-Castellar G; Gibson B; Santoscoy S; Vargas-Estrella B
    JMIR Form Res; 2022 Mar; 6(3):e35066. PubMed ID: 35191841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of, and barriers and facilitators to, a pilot physical health service for people who inject drugs: A qualitative study with service users and providers.
    Anderson NC; Kesten JM; Ayres R; Hickman M; Amlôt R; Michie S; Lorencatto F
    Int J Drug Policy; 2022 Jan; 99():103437. PubMed ID: 34600415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia.
    Schroeder SE; Treloar C; Bourne A; Stoové M; Doyle J; Hellard M; Pedrana A
    Qual Health Res; 2023 Jul; 33(8-9):688-700. PubMed ID: 37219452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Discrimination perceived by people with a diagnosis of schizophrenic disorders. INternational study of DIscrimination and stiGma Outcomes (INDIGO): French results].
    Daumerie N; Vasseur Bacle S; Giordana JY; Bourdais Mannone C; Caria A; Roelandt JL
    Encephale; 2012 Jun; 38(3):224-31. PubMed ID: 22726410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers.
    Muller A; Akiyama MJ; Riback L; Nyakowa M; Musyoki H; Cherutich P; Kurth A
    Int J Drug Policy; 2022 Jul; 105():103710. PubMed ID: 35580533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breaching Trust: A Qualitative Study of Healthcare Experiences of People Who Use Drugs in a Rural Setting.
    Ellis K; Walters S; Friedman SR; Ouellet LJ; Ezell J; Rosentel K; Pho MT
    Front Sociol; 2020; 5():593925. PubMed ID: 33869521
    [No Abstract]   [Full Text] [Related]  

  • 36. Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting.
    Rudzinski K; Chan Carusone S; Ceranto A; Ibáñez-Carrasco F; McDonald L; Valentine D; Guta A; Hyshka E; O'Leary W; Cardow A; Strike C
    Harm Reduct J; 2022 Nov; 19(1):124. PubMed ID: 36384634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative study on health stigma and discrimination in the first year of the COVID-19 pandemic: Lessons learnt from a public health perspective.
    Yu CC; Tang B; Low JA; Mathew M; Straus S; Fahim C
    Front Public Health; 2023; 11():1143640. PubMed ID: 36935669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internalized Stigma Among People Who Inject Drugs.
    Cama E; Brener L; Wilson H; von Hippel C
    Subst Use Misuse; 2016 Oct; 51(12):1664-1668. PubMed ID: 27459264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
    Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
    Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
    Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
    Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.